Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oleksii Voskoboinik

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|May 6, 2020
Substituted 3-R-2,8-Dioxo-7,8-dihydro-2H-pyrrolo[1,2-a][1,2,4] triazino [2,3-c]quinazoline-5a(6H)carboxylic Acids and their Salts - a Promising Class of Anti-inflammatory AgentsViktor Stavytskyi, Oleksii Antypenko, Inna Nosulenko, et al.
Acta Chimica Slovenica|November 5, 2021
Quinazoline-containing Hydrazydes of Dicarboxylic Acids and Products of Their Structural Modification: A Novel Class of Anti-inflammatory AgentsNataliia Krasovska, Viktor Stavytskyi, Inna Nosulenko, et al.
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|January 23, 2026
Novel pyrazole bearing heterocyclic hybrids as promising biologically active compoundsKostiantyn Shabelnyk, Yevhen Zaika, Dmytro Skoryna, et al.
Acta Chimica Slovenica|April 1, 2026
Synthesis, structure and photophysical properties of novel thiazolo[2,3-b]pteridinesDaryna Kyrylova, Oleksii Voskoboinik, Anatolii Tatarets, et al.
Chemistry & Biodiversity|June 19, 2026
Benzo[e][1,2,4]triazolo[1,5-c][1,2,3]triazines: Design, Synthesis, and Cytotoxic EffectsSerhii Sinyavskyi, Svitlana Koptieva, Oleksii Voskoboinik, et al.
European Journal of Medicinal Chemistry|January 18, 2024
5+1-Heterocyclization as preparative approach for carboxy-containing triazolo[1,5-c]quinazolines with anti-inflammatory activityNatalya Krasovska, Galina Berest, Igor Belenichev, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2,4]triazino[2,3-c]quinazolinesOleksandr Grytsak, Kostiantyn Shabelnyk, Hanna Severina, et al.
Frontiers in Endocrinology|October 6, 2025
Future horizons in diabetes treatment: hypoglycemic activity of [1,2,4]triazino[2,3-<i>c</i>]quinazoline derivativesSerhii Trzhetsynskyi, Inna Nosulenko, Anna Kinichenko, et al.
Biomedicines|June 26, 2025
The Application of S-Substituted Pteridine for CCl<sub>4</sub>-Induced Acute Hepatitis Treatment in RatsNatalia Lohvinenko, Volodymyr Shvets, Oleksii Antypenko, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and ActivityKostiantyn Shabelnyk, Alina Fominichenko, Oleksii Antypenko, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|May 6, 2020
Substituted 3-R-2,8-Dioxo-7,8-dihydro-2H-pyrrolo[1,2-a][1,2,4] triazino [2,3-c]quinazoline-5a(6H)carboxylic Acids and their Salts - a Promising Class of Anti-inflammatory AgentsViktor Stavytskyi, Oleksii Antypenko, Inna Nosulenko, et al.
Acta Chimica Slovenica|November 5, 2021
Quinazoline-containing Hydrazydes of Dicarboxylic Acids and Products of Their Structural Modification: A Novel Class of Anti-inflammatory AgentsNataliia Krasovska, Viktor Stavytskyi, Inna Nosulenko, et al.
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|January 23, 2026
Novel pyrazole bearing heterocyclic hybrids as promising biologically active compoundsKostiantyn Shabelnyk, Yevhen Zaika, Dmytro Skoryna, et al.
Acta Chimica Slovenica|April 1, 2026
Synthesis, structure and photophysical properties of novel thiazolo[2,3-b]pteridinesDaryna Kyrylova, Oleksii Voskoboinik, Anatolii Tatarets, et al.
Chemistry & Biodiversity|June 19, 2026
Benzo[e][1,2,4]triazolo[1,5-c][1,2,3]triazines: Design, Synthesis, and Cytotoxic EffectsSerhii Sinyavskyi, Svitlana Koptieva, Oleksii Voskoboinik, et al.
European Journal of Medicinal Chemistry|January 18, 2024
5+1-Heterocyclization as preparative approach for carboxy-containing triazolo[1,5-c]quinazolines with anti-inflammatory activityNatalya Krasovska, Galina Berest, Igor Belenichev, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2,4]triazino[2,3-c]quinazolinesOleksandr Grytsak, Kostiantyn Shabelnyk, Hanna Severina, et al.
Frontiers in Endocrinology|October 6, 2025
Future horizons in diabetes treatment: hypoglycemic activity of [1,2,4]triazino[2,3-<i>c</i>]quinazoline derivativesSerhii Trzhetsynskyi, Inna Nosulenko, Anna Kinichenko, et al.
Biomedicines|June 26, 2025
The Application of S-Substituted Pteridine for CCl<sub>4</sub>-Induced Acute Hepatitis Treatment in RatsNatalia Lohvinenko, Volodymyr Shvets, Oleksii Antypenko, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and ActivityKostiantyn Shabelnyk, Alina Fominichenko, Oleksii Antypenko, et al.
Pageof 1